Why we are here
We believe
Everybody deserves to live a healthy, balanced life
Cannabis’ Potential
After decades of scientific negligence of the cannabis plant, more and more research is proving what people already knew thousands of years ago: That cannabis can have a positive impact on peoples’ lives.
Our Purpose
Unlock the benefits of cannabis for health and wellbeing and make them widely accessible to people in Europe.
All over the world, scientific discoveries and their medical potential are redefining the way society, politics and the medical community think about cannabis as a plant. In the past 5 years, more things have moved forward than in the 50 years before.
Amidst the ongoing legalization for medical and recreational purposes in North America and all around the world, Europe is following its own path. With more than 700 million inhabitants in continental Europe and 500 million within the EU, the market for cannabis is estimated to surpass 100 billion EUR by 2028.
Born out of Europe’s biggest market for Cannabis, Germany, Sanity Group specializes in Europe and its very distinct, localized markets, each with its own unique regulation, healthcare system and needs.
Research Backlog
We explore cannabis’ potential with research and development
Missing Access
Distorted Perception
We address cannabis’ image with our medical and political advisory board of experts
Sanity Medical
Sanity Medical focuses on the development and distribution of innovative cannabis pharmaceuticals on the way to become the number one independent European medical cannabis authority.
Sanity Care
Sanity Science
Sanity Science carries out R&D projects and produces high quality extracts for all operational business areas.
